Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1996, 493-499, Vol 3, No. 5
BN Lee, JG Lu, MW Kline, M Paul, M Doyle, C Kozinetz, WT Shearer and JM Reuben
In human immunodeficiency virus (HIV)-infected adults, cytokine production
profiles switch from predominantly type 1 (interleukin-2 [IL- 2] and gamma
interferon [IFN-gamma]) to type 2 (IL-4 and IL-10) cytokines with disease
progression. To test this hypothesis in vertically HIV-infected children,
we measured cytokine transcription and production in rapid progressors
(RPs), seroreverters (SRs), and those children exposed to HIV in utero
(P0s). Production of type 1 and type 2 cytokines was measured in peripheral
blood mononuclear cell cultures of 8 SR, 25 P0, and 11 RP children.
Unstimulated cultures, irrespective of infection and stage of disease,
produced similar levels of IL-2, IFN-gamma, IL-4, and IL-10. Upon
stimulation with phytohemagglutinin (PHA) plus
phorbol-12-myristate-13-acetate (PMA), RP children produced less IL-2 (P
< 0.01) and IFN-gamma (P < 0.02) than SR children and also expressed
significantly less IFN-gamma mRNA (P < 0.01) than SR children. RP
children expressed significantly higher levels of IL-4 mRNA than P0
children (P < 0.03). There were no differences in the production of
IL-10 by PHA-PMA-stimulated peripheral blood mononuclear cell cultures
among the three groups of children. Our data with these pediatric patients
suggest that a deficiency in mitogen- stimulated type 1 cytokine production
and excess type 2 cytokine (IL-4) transcription correlate with disease
progression. Additional studies with larger sample sizes are needed to test
further the hypothesis of the type 1-to-type 2 cytokine switch in children
infected with HIV.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus
Division of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |